Weston Nichols is 10% Owner at TScan Therapeutics, Inc. (TCRX). They have made 4 open-market trades across 3 companies since 2024, most recently 2026-06-18.
CIK 0001746376
4 open-market purchases totalling $3.5M since 2024, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| CGEM | 8,963,500 | $115.7M |
| PASG | 611,804 | $2.2M |
| CRNX | 22,225 | $1.9M |
| TCRX | 7,500,000 | $1.8M |
| Total | $121.6M |
Shares reported on the most recent Form 4, priced at the 2026-06-22 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.